Global Head of Device Development

As the Global Head of Device Development, you are an enterprise leader and a key contributor to the One Pharma Strategy (OPS). You are responsible for the realization of the Device and Delivery Systems (DDS) strategy, ensuring Roche remains the industry benchmark for patient‑centric delivery technologies. You will lead a strong technical organization of over 120 scientific and engineering professionals with different experiences and backgrounds.

• Shape the end‑to‑end platform strategy under DDS, from early‑stage design through industrialization and commercial lifecycle management to create maximum impact.
• Lead and support the company‑wide Technical Development (CMC) device portfolio, ensuring breadth and depth of technical capabilities, shared learning, and continuous improvement culture.
• Act as the primary decision‑maker for development technology investments and platform selection in conjunction with PT device community leaders, chair the Global Device Review Forum (GDRF) and serve as a key member of the LSTDC for combination product topics.
• Partner successfully with internal stakeholders to influence the external manufacturing network strategy, ensuring contract development and manufacturing organization (CDMO) partners are technically enabled to support patient‑centric delivery systems.
• Enable “Design for Sustainability” principles of DDS, ensuring new device architectures are compatible with future environmental standards and circular economy initiatives.

• Lead the Global PT Device Community in a “Collective Leadership” model and collaborate deeply with Device and Packaging Industrialization (MSAT) teams, Pharmaceutical Development, Device Quality, and Regulatory to ensure an integrated approach to combination product health.
• Forge strong and reliable relationships with Head of R&D units (gRED, pRED), Product Development, and Global Product Strategy to influence clinical development strategies and integrate device platforms early and effectively.
• Act as an executive representative with Global Health Authorities and external strategic partners.
• Lead the external influencing agenda for combination product regulations and standards.

• Accelerate the development of the Next Generation of device platforms, including high‑volume Auto‑Injectors (3‑5mL), pen platform, and high‑volume delivery system.
• Embed Data, Digital, and AI capabilities into leadership and into device design.
• Transition and further shape the organization toward a “Lab of the Future” model, utilizing predictive modeling and automated testing to accelerate design verifications and exceptional user experiences.

• Instill a culture of technical rigor to eliminate operational friction and raise process efficiency, ensuring all foreseeable risks are identified early and mitigated with urgency (Right First Time).
• Drive Lean/Operational Excellence principles to achieve productivity goals by leveraging platform knowledge and design histories.
• Actively motivate, mentor and develop “Ready Now” successors and rising stars.
• Foster an inclusive environment reflecting Roche’s commitment to inclusion and belonging.
• Embody and role model Roche values and VACC (Visionary, Architect, Catalyst, Coach) leadership principles.

• Advanced degree in Engineering (Mechanical, Biomedical, or Chemical), Life Sciences, or a related technical field is required.
• Extensive years of experience in the medical device, Biotechnology, and Pharmaceutical industry, with several years leading large, complex technical organizations.
• Proven track record of navigating the complexities of CMC development from inception through commercialization.
• Demonstrated ability to evolve systems, processes, or organizations to maximize impact.
• Broad understanding of drug development, with specific expertise in combination products, human factors engineering, and design controls (21
  
  CFR Part4, ISO
  14971, ISO
  13485, MDR, and 21
  
  CFR
  820).
• Exceptional communication skills and…